You are here
First Manhattan Street Capital offering in the Biomaterials market launched-Regulation A+
We are pleased to announce that Manhattan Street Capital's first Company offering in the Biochemicals market is now live, in Regulation A+ TestTheWaters(TM) mode!
Blue Marble Biomaterials, of Missoula, Montana intends to raise growth capital through a Regulation A+ offering on Manhattan Street Capital's funding platform.
Blue Marble is the first biomaterials company to file an intent to offer equity shares to the public via Regulation A+.
“Manhattan Street Capital has been instrumental in the launch of our Regulation A+ online public offering,” said Colby Underwood, co-CEO of Blue Marble Biomaterials.
1,400 companies have joined Manhattan Street Capital's funding platform to evaluate raising growth capital by using Regulation A+.
Since the inception of Regulation A+ in 2015, Manhattan Street Capital has been a frontrunner in the effort to educate growth stage companies about the potential advantages Regulation A+ embodies, such as post investment liquidity, that investors at any wealth level worldwide can participate, brand building and providing more control for founders over their funding path, along with new funding alternatives that are streamlined and less expensive than traditional IPOs and provide more flexibility – well suited to mid-sized companies.
Manhattan Street’s founder and CEO Rod Turner is an expert on Regulation A+ and other funding alternatives, and has advised some 300 companies on the suitability of Regulation A+ for their companies thus far. The company is working with a roster of companies in the process of preparing for upcoming offerings, and working with Manhattan Street’s selected marketing agencies and other service providers such as Broker-Dealers and underwriters.
Turner provides monthly Reg A+ Updates from the ManhattanStreetCapital.com blog, is a frequent columnist and presenter, and is also an ongoing columnist for Forbes.com.
"We begin our process by helping companies assess if Regulation A+ is a good fit for their business and their capital raising plans,” Turner said. “We introduce them to the service providers they need for successful Regulation A+ offerings, and we list their offerings and integrate them with the necessary back-end systems on our website, while levering the proprietary technology built into our platform.”
Manhattan Street advises companies through the fundraising process to increase the success and efficiency of the offerings on its platform.
“We specialize in Reg A+,” Turner continued. “We focus on the more established businesses for which Regulation A+ is uniquely well suited.”
Manhattan Street Capital, Inc. (www.manhattanstreetcapital.com), in San Diego, Calif., is the #1 growth capital marketplace for midstage companies, building on the Reg A+ SEC rules that allow main street investors worldwide to make an impact by investing growth capital in midmarket companies.
VidAngel set the fastest Regulation A+ raise rate in October: They raised $10 mill from 7,550 investors, in 5 days of live funding. More on VidAngel.
See the latest Regulation A+ Update.
Click here for guidance on how to make your companies' Reg A+ offering a success
Regulation A+ recap: In June 2015 Title IV of the JOBS Act opened the door for main street (non-accredited) investors worldwide to invest in private companies having headquarters in the USA or Canada. Regulation A+ funding offers cost effective capital raising for mid-stage companies and mature startups, and provides investors convenient access to company offerings at their issue price. Also advantageous: the shares are liquid post offering. Summary of Reg A+ here.
Learn more using the Manhattan Street Capital FAQ
Rod Turner is the founder and CEO of Manhattan Street Capital, the #1 Growth Capital marketplace for mature startups and mid-sized companies to raise capital using Regulation A+. Turner has played a key role in building successful companies including Symantec/Norton (SYMC), Ashton-Tate, MicroPort, Knowledge Adventure and more. He is an experienced investor who has built a Venture Capital business (Irvine Ventures) and has made angel and mezzanine investments in companies such as Bloom, Amyris (AMRS), Ask Jeeves and eASIC.
Manhattan Street Capital, 5694 Mission Center Rd, Suite 602-468, San Diego, CA 92108. Phone 1 858 366 2585
NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED AND, IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL THE OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION. AN INDICATION OF INTEREST INVOLVES NO OBLIGATION OR COMMITMENT OF ANY KIND.